Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Abbvie Inc (ABBV)

2014-04-18@20:43:58 ET
AbbVie Inc.Corporate Event Announcement Notice (WSH)

2014-04-18@20:37:28 ET
AbbVie Inc.Corporate Event Announcement Notice (WSH)

2014-04-18@07:10:53 ET
Glaxo Looking into Misconduct Charges (ZAX)

2014-04-17@14:26:55 ET
Glaxo's Tanzeum Approved in the U.S. (ZAX)

2014-04-16@11:00:00 ET
Application Now Open for Students with Cystic Fibrosis for the 2014 AbbVie CF Scholarship (PRN)

2014-04-15@11:21:51 ET
US Patent Issued to AbbVie, AbbVie Deutschland on April 8 for "Anti-A globulomer 5F7 antibodies" (German, American Inventors) (ABW)

2014-04-15@08:00:00 ET
AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) for Patients with Non-Small Cell Lung Cancer (PRN)

2014-04-12@01:00:00 ET
AbbVie to Present Late-Breaking Results from TURQUOISE-II Study in Chronic Hepatitis C Patients with Cirrhosis at the 2014 International Liver Congress(TM) (PRN)

2014-04-11@01:00:00 ET
AbbVie to Present Detailed Phase III Results from SAPPHIRE-I and SAPPHIRE-II Studies in Chronic Hepatitis C Patients at the 2014 International Liver Congress(TM) (PRN)

2014-04-03@11:23:17 ET
US Patent Issued to AbbVie on April 1 for "Anti-infective agents and uses thereof" (Illinois, Wisconsin Inventors) (ABW)

2014-04-03@08:00:00 ET
Financial Results, Launches, Adjusted Conversion Rates, Upcoming Presentations, and Stock Movements - Analyst Notes on AbbVie, Chemed, Antares Pharma, Magellan Health Services, and Natus Medical (PRN)

2014-04-03@07:50:23 ET
US Patent Issued to AbbVie on April 1 for "Solid compositions" (German, American Inventors) (ABW)

2014-04-01@08:22:39 ET
AndroGel Lawyers at Parilman & Associates React to Lawsuit Filed Against AbbVie, Inc. Alleging Link between Testosterone Drug and Blood Clots (PRW)

2014-03-31@01:21:24 ET
Lupin Pharmaceuticals launches generic anti-lipidemia tablets (DTM)

2014-03-26@07:17:27 ET
Global Dermatological Drugs Market 2014-2018: The Global Dermatological Drugs Market is Expected to Reap Large Revenues with Increasing Use of Biologics (MTO)

2014-03-24@05:00:00 ET
AbbVie to Present Detailed Results from Phase III Studies in Patients with Chronic Hepatitis C at the 2014 International Liver Congress(TM) (PRN)

2014-03-21@20:38:39 ET
AbbVie Inc.Corporate Event Announcement Notice (WSH)

2014-03-21@18:44:00 ET
Health Care Sector Equities Technical Commentary -- Research on AbbVie, GlaxoSmithKline, AstraZeneca and Novartis (PRN)

2014-03-20@20:37:27 ET
AbbVie Inc.Corporate Event Announcement Notice (WSH)

2014-03-20@09:22:18 ET
AbbVie Initiates New Clinical Trial to Evaluate HUMIRA(R) (adalimumab) for the Treatment of Fingernail Psoriasis in Patients with Moderate to Severe Chronic Plaque Psoriasis (EUR)